Variant report
Variant | nsv555110 |
---|---|
Chromosome Location | chr11:58594662-58595962 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565625133 | chr11:58594663-58594664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201478667 | chr11:58594820-58594821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530650196 | chr11:58594859-58594860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536187627 | chr11:58594923-58594924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs548165533 | chr11:58594963-58594964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569554260 | chr11:58594971-58594972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183706335 | chr11:58595020-58595021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34366794 | chr11:58595074-58595075 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs578197950 | chr11:58595135-58595136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs539217561 | chr11:58595136-58595137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12418392 | chr11:58595143-58595144 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs10896843 | chr11:58595206-58595207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542951449 | chr11:58595266-58595267 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs565281644 | chr11:58595267-58595268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534288321 | chr11:58595268-58595269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561294744 | chr11:58595277-58595278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149620392 | chr11:58595280-58595281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543869136 | chr11:58595281-58595282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565016023 | chr11:58595291-58595292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532505749 | chr11:58595292-58595293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78866125 | chr11:58595293-58595294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs201030507 | chr11:58595294-58595295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs559170683 | chr11:58595312-58595313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529891266 | chr11:58595325-58595326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539015252 | chr11:58595334-58595335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs188343724 | chr11:58595340-58595341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181118255 | chr11:58595341-58595342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10896844 | chr11:58595384-58595385 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs552180316 | chr11:58595429-58595430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184891598 | chr11:58595492-58595493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534755227 | chr11:58595507-58595508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189776768 | chr11:58595530-58595531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs181786362 | chr11:58595531-58595532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs566283108 | chr11:58595533-58595534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536916809 | chr11:58595545-58595546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs554985657 | chr11:58595558-58595559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576701218 | chr11:58595625-58595626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs137941623 | chr11:58595659-58595660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558570361 | chr11:58595678-58595679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576923845 | chr11:58595716-58595717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs11229648 | chr11:58595718-58595719 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs559082314 | chr11:58595719-58595720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs186908436 | chr11:58595720-58595721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529866255 | chr11:58595742-58595743 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542082426 | chr11:58595763-58595764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112218741 | chr11:58595770-58595771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567258692 | chr11:58595771-58595772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190793994 | chr11:58595780-58595781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs7127614 | chr11:58595883-58595884 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs551880809 | chr11:58595885-58595886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495309 | CNVD |
Autism | 20808228 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Cancer | 20164919 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:58593000-58596600 | Weak transcription | HMEC | breast |
2 | chr11:58593200-58596600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr11:58595600-58598600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |